An Inverse Relationship Between Ceramide Synthesis and Clinical Severity in Patients with Psoriasis by Cho, Yunhi et al.
INTRODUCTION
The fundamental function of the epidermis is the provision
of an efficient barrier against water loss through the skin (1).
This epidermal barrier is formed from the extracellular lipid-
enriched membranes of the stratum corneum and is organized
into membranous multilayers with a repetitive lamellar struc-
ture. The intercellular lipid lamellae is composed predomi-
nantly of ceramides, cholesterol, and fatty acids which origi-
nate from polar lipid precursors provided by cells in the basal
layer of the epidermis (2, 3).
Ceramides are the main lipids of the stratum corneum (3,
4). During keratinization, almost all of the epidermal phos-
pholipids, found abundantly in the basal layer, disappear and
ceramides, synthesized de novo from phospholipid interme-
diates, remain within the stratum corneum (4). Ceramide-rich
intercellular lipid lamellae are thought to be of particular
importance in maintaining the structural integrity of epider-
mal barrier (5, 6). Depletion of ceramides in the stratum cor-
neum has been suggested as an etiological factor for dryness
and barrier disruption in skin conditions such as atopic der-
matitis and essential fatty acid deficiency (EFAD) (7-10). The
marked depletion of ceramides in the stratum corneum was
reported in the patients of atopic dermatitis (7, 8). In essen-
tial fatty acid (EFA)-deficient animals, reduction in the levels
of lipids, especially ceramides, was shown to bear a correla-
tion to disruptions in the epidermal barrier (9, 10). Several
investigators have already addressed the question of altered
epidermal ceramide distribution in psoriasis; a negative cor-
relation between ceramide content and transepidermal water
loss has been suggested (11-17). However, only limited infor-
mation is yet available on alterations in the synthesis, not the
level, of epidermal ceramides in conditions involving skin
dryness and barrier disruption, including psoriasis. In this
study, the alterations in epidermal ceramide synthesis as asse-
ssed using [14C]serine, and its correlation with the clinical
severity was examined in patients with psoriasis. 
MATERIALS AND METHODS
Patients and skin biopsies
Ten Korean psoriasis patients (2 women; 8 men) ranging
in the age from 21 to 35 yr took part in the present study
involving ceramide synthesis. Six Korean psoriasis patients
(2 women: 4 men) ranging in the age from 15 to 34 yr took
part in the part of the present study involving fatty acid anal-
ysis. All of the subjects, who had given their informed consent,
had psoriasis vulgaris as identified through clinical and his-
tological assessment and have not been treated either system-
ically or topically for at least 1 month prior to punch biopsy.
Biopsies using 4-mm punch were taken from the lesional
or unlesional skin of the lower extremities, back or arms. Sep-
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An Inverse Relationship Between Ceramide Synthesis and Clinical
Severity in Patients with Psoriasis
Ceramides play major roles in maintaining the epidermal barrier. It has been sus-
pected that the depletion of ceramides, associated with disrupted barrier function in
the epidermis, leads to the clinical manifestation of dryness and inflammation seen
in patients with psoriasis. The aim of the present study was to determine the relation-
ship between the level of ceramide synthesis in the epidermis and the clinical severity
in patients with psoriasis. Samples from lesional and unlesional epidermis obtained
from psoriasis patients were incubated with [
14C]serine, an initiator of ceramide syn-
thesis. Total ceramide was fractionated using high performance thin layer chromato-
graphy, and the radioactivity was measured. The clinical severity of psoriasis was
graded according to the psoriasis area and severity index scoring system. The level
of ceramide synthesis in the lesional epidermis of patients was significantly lower
than that in the unlesional epidermis and bore a negative correlation with the clinical
severity of psoriasis. The present results suggest that the decreased level of ceramide
synthesis in the epidermis contributes to the clinical severity of psoriasis.
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aration of the epidermis was done as described previously (14):
specifically, the epidermis was separated from whole skin biop-
sies by overnight incubation at 4℃in a one to one (v/v) mix-
ture of Dispase solution (Roche Molecular Biochemicals, Man-
heim, Germany) and Hank’s balanced salt solution (HBSS)
(Gibco BRL, Life Technologies, Rockville, MD, U.S.A.). 
Assessment of clinical severity of psoriasis
The clinical severity was assessed using the psoriasis area
and severity index (PASI) scoring system. The PASI score is
calculated as follows: PASI=0.1(Eh+Ih+Dh)Ah+0.2(Eu+Iu+Du)
Au+0.3(Et+It+Dt)At+0.4(El+Il+Dl)Al, where E=erythema;
I=infiltration; D=desquamation; A=area; h=head; u=upper
extremities; t=trunk; l=lower extremities. A numerical value
is given to the extent of the lesions in each area: 1=<10%;
2=10-30%; 3=30-50%; 4=50-70%; 5=70-90%; and 6=
90-100%. E, I, and D are scored according to a five-point
scale (0=no symptoms; 1=slight; 2=moderate; 3=marked;
4=very marked) to obtain a final PASI score between 0 and
72. The PASI score of the patients who took part in this study
ranged between 2.4 and 22.4; this range corresponds to mild
and moderate psoriasis. Only those patients with PASI<25
were enrolled in this study in order to determine whether
alterations in the level of either ceramide synthesis or fatty
acids bear a close-enough correlation to the clinical severity
in mild to moderate status of psoriasis.
Assessment of the level of de novo synthesis of ceramides
Because the process of ceramide synthesis is initiated by
incorporation of serine, ceramide synthesis was determined
by incubating the separated epidermis (4-mm punch biopsy
specimen) in 1 mL Krebs bicarbonate buffer (pH 7.5) contain-
ing [14C]serine (0.1  Ci/mL) at 37℃for 16 hr as a previously
described method (15). After incubation, the epidermis was
washed with PBS and homogenized. The total lipids were
extracted using a CHCl3: MeOH (2:1, v/v) mixture. The ex-
tracted lipids (lower phase) were subjected to high performance
thin layer chromatography (HP-TLC) on 0.20-mm silicagel
60-coated plates (Whatman, Clifton, NJ, U.S.A.) according
to the modified method reported by Uchida et al. (16). Specif-
ically, the samples applied on the plates were first eluted up
to 1.0 cm and then up to 3.5 cm using a CHCl3: MeOH:
acetone (76: 20:4, v/v/v) solution, then up to 7.5 cm using a
CHCl3: Acetone: MeOH (80:10:10, v/v/v) solution, and finally
up to the top using a CHCl3: Ethylacetate: Ether: MeOH
(76:20:6:2, v/v/v/v) solution. Each stage of elution was car-
ried out after the plates were completely air-dried. The cera-
mide-containing fractions that comigrated with their respec-
tive standards were visualized by 2,7-dichlorofluorescein spray
and eluted from the plates using a CHCl3:MeOH (2:1, v/v)
solution. The eluates were dried in N2 gas and the radioactiv-
ity was measured using a Beckman scintillation counter.
To compare each samples, the level of radioactivity was nor-
malized according to the amount of protein extracted from
the separated epidermis. The upper phase of lipid extraction
stage, which contained epidermal homogenates, was centrifug-
ed at 800 g for 5 min to remove tissue debris, and the protein
concentration was determined according to the modified Lowry
method (17) using bovine serum albumin as a standard. De
novo synthesis of ceramides was assessed as cpm/ g protein. 
Fatty acid analysis
Fatty acids are found chiefly in the intercellular lipid lamel-
lae of the epidermal barrier (2, 3). The fatty acid profiles of
the total lipid contents extracted from the separated epidermis
were determined by gas chromatography after transmethyla-
tion in 6% methanolic HCl (18). The gas chromatography
device employed (Hewlett-Packard 5730A) was equipped
with a SPB-225-fused silica capillary column (30 m×0.25
mm×0.15  m, Supelco, Bellefonte, PA, U.S.A.) with an ini-
tial oven temperature of 140℃which increases by 4℃/min
to a final temperature of 240℃. Detection was performed
by using a flame ionization detector (FID). Methylheptade-
canoate was used as an internal standard to assess the relative
amounts of various fatty acids. The separated fatty acids were
also identified by comparing retention times of the external
standards (Supelco, Bellefonte, PA, U.S.A.).
Statistical analysis
Statistical significance of the differences in the levels of
ceramide synthesis and fatty acids between lesional and unle-
sional samples of psoriasis patients was assessed by paired t-
test. Correlation between the levels of ceramide synthesis and
PASI scores was determined using Pearson correlation test.
p-values<0.05 were considered to be statistical significance.
RESULTS
Ceramide synthesis and PASI scores in patients with
psoriasis
The levels of ceramide synthesis in the lesional and unle-
sional epidermis, and the PASI scores of the subjects are shown
in Table 1. Although the absolute level of ceramide synthesis
differed between the patients, the level of ceramide synthesis
in the lesional epidermis was always significantly less (p<0.01)
than that in the unlesional epidermis, with the percentage
reduction ranging from 4.32 to 78.80. A highly significant
positive correlation between the percentage reduction of ce-
ramide synthesis and PASI score was observed (r=0.967, p=
0.0004), as shown in Fig. 1. These results indicate that the
level of ceramide synthesis is inversely correlated with the PASI
score in mild to moderate psoriasis. Epidermal Ceramide Synthesis and Clinical Severity of Psoriasis 861
Fatty acid analysis
The levels of fatty acids were analyzed from total lipid ex-
tracts of lesional and unlesional epidermis of subjects (Table
2). The levels of saturated fatty acids such as palmitic (16:0)
and stearic acids (18:0) were higher than the overall level of
unsaturated fatty acids. However, there were no significant
differences in the levels of these fatty acids between lesional
and unlesional epidermis. Furthermore, the level of linoleic
acid (18:2n-6), a major unsaturated fatty acid which is essen-
tial for maintaining the epidermal barrier (20, 21), was not
altered in the lesional epidermis of the subjects. In addition,
no correlation was observed between the level of fatty acids
and the PASI score (data not shown). 
DISCUSSION
Although decreased ceramide levels have been reported in
skin conditions involving dryness and barrier disruption such
as psoriasis (7-17), alterations in the level of ceramide synthesis
in this context has not been examined, and the possible rela-
tionship between such change and the clinical severity of pso-
riasis even less. The present study shows that the level of cera-
mide synthesis is significantly reduced in the lesional epider-
mis, which inversely correlates with the clinical severity in
mild to moderate psoriasis. 
The epidermal barrier assumes the structure of a lipid-enri-
ched multilamellae in the stratum corneum, which lipid con-
tent is predominantly composed of ceramides, cholesterol and
free fatty acids (2, 3). Ceramides bearing the moieties of amide-
linked non-hydroxy acid,  -hydroxy acid, or  -hydroxy acid
and ester-linked fatty acids on sphingosine provide the driv-
ing force for lamellar assembly (19), and these structural moi-
eties are thought to be important in maintaining the struc-
tural integrity of epidermal barrier against water loss through
the skin (5, 6). Correspondingly, decreases in the level of ce-
ramides have been associated with skin conditions involving
dryness and barrier disruption, such as atopic dermatitis (7, 8),
EFAD (9, 10), xerosis (21), and psoriasis (11-17). Such skin
conditions are characterized by changes in the levels of free
fatty acids, especially linoleic acid (LA) (18:2n-6) (19, 20).
The lamellar granules in linoleate-deficient animals have
been reported to contain amorphous and consequently only
fragmentary lamellae in the stratum corneum (20). In view
of the functional importance of LA in maintaining the struc-
tural integrity of the epidermal barrier (19, 20), the linoleate
moiety of ceramide 1 thus appears to favor lipid lamellar
packing (22). However, the assessment of the lesional epider-
mis of psoriasis patients revealed no alteration in the levels
of LA or other fatty acids compared with the unlesional epi-
dermis of the same patients (Table 2). In addition, no rela-
tionship was observed between the levels of fatty acids and
the PASI score in mild to moderate psoriasis. On the other
hand, the level of ceramide synthesis was significantly reduced
in the lesional epidermis of patients (Table 1). These results
are in concordance with the results of earlier studies in which
decreases in the levels of ceramides, specifically ceramide 1,
4, and 5, have been shown to be associated with increased
transepidermal water loss in the psoriatic epidermis (11). Fur-
thermore, a positive correlation between the percentage reduc-
tion of ceramide synthesis in the lesional epidermis and clin-
*% reduction was calculated as [(unlesioned level lesioned level)/unle-
sioned level]×100. 
� p<0.01 by paired t-test.
Patient No. PASI score 
Ceramide synthesis (cpm/ g protein)
Unlesional Lesional % Reduction*
1 3.70 3.54 4.32 2.4
2 15.11 13.49 10.72 4
3 2.14 1.51 29.4 6.9
4 3.66 2.12 42.08 8.7
5 5.74 3.68 35.89 9.8
6 6.46 3.66 43.35 14
7 4.48 2.29 48.88 16.8
8 13.56 5.50 59.44 20.1
9 9.97 2.38 76.13 23
10 10.71 2.27 78.80 22.4
Mean±SEM 7.56±1.42 4.04±1.11
�
Table 1. Levels of ceramide synthesis in unlesional and lesional
epidermis and PASI scores of subjects
*Values are mean±SD (n=6); 
� Only major fatty acids are listed; 
� No sta-
tistical significance according to paired t test.
Fatty acid p
(g/100 g total fatty acids)
Unlesional Lesional
16:0
� 16.03±2.69 14.26±2.47 NS
�
18:0 20.27±2.40 19.83±3.69 NS
18:1n-9 3.75±1.65 2.80±0.12 NS
18:2n-6 1.67±0.81 1.64±0.24 NS
18:3n-3 0.15±0.06 0.15±0.09 NS
20:4n-6 0.22±0.07 0.19±0.06 NS
Table 2. Fatty acid profile of unlesional and lesional epidermis
of subjects*
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Fig. 1. Correlation between percentage reductions of ceramide
synthesis in lesional epidermis and PASI scores of subjects.862 Y. Cho, B.-L. Lew, K. Seong, et al.
ical severity (r=0.967, p=0.0004) has been demonstrated in
this study (Fig. 1). Only those patients with mild to moder-
ate psoriasis took part in our study, our data demonstrate that
reduction of ceramide synthesis in the lesional epidermis is
sensitive enough to make an inverse correlation with clinical
severity in mild to moderate status of psoriasis.
The level of ceramides in the epidermis is regulated by a
balance in the activity of ceramide generating enzymes such
as serine palmitoyl transferase in the de novo synthesis path-
way, sphingomyelinase, and  -glucocerebrosidase and that
of the degradative enzyme such as ceramidase (23). Ceramides
in the stratum corneum are originally derived from sphin-
gomyelin and  -glucosylceramides. No apparent difference
in sphingomyelinase and  -glucocerebrosidase activities was
observed between patients with atopic dermatitis and aged-
matched controls (23, 24). As opposed to the usage of stripped
stratum corneum in previous studies (23, 24), the whole epi-
dermis was used in the present study. The percentage reduc-
tion of ceramide synthesis was observed in this study together
with the finding that no change in sphingomyelinase and  -
glucocerebrosidase activities is observed in the stratum cor-
neum (23, 24), which seems to indicate a depression in the
activity of serine palmitoyl transferase in the lesional epider-
mis of psoriasis patients. Extremely high activities of cerami-
dase (25) and sphingomyelin deacylase (26), which hydrolyze
sphingomyelin into sphingophosphorylcholine and free fatty
acid, have been demonstrated to be the metabolic features
leading to low levels of ceramides in the stratum corneum
in atopic dermatitis; however, ceramidase activity was not
altered in the stratum corneum in psoriasis (25). Together
with these findings, the present data suggest that the dramatic
reduction in ceramide synthesis, which has been found to
bear a significant correlation to the clinical severity, is caused
by a decrease in the activity of serine palmitoyl transferase.
However, the complete relationship between ceramide con-
tent and activity of ceramide-metabolizing enzymes in the
psoriatic skin remains to be clarified.
In conclusion, we demonstrate that the level of ceramide
synthesis is significantly reduced in the lesional epidermis,
which is sensitive enough to make an inverse correlation with
clinical severity in mild to moderate status of psoriasis. We
are not certain whether this finding is primary or secondary
event in psoriasis. However, we suggest that the reduction
of synthetic capacity of ceramide is the important one of the
severity-related factors.
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